RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials

Author:

Oronsky Bryan1,Paulmurugan Ramasamy2,Foygel Kira2,Scicinski Jan1,Knox Susan J.3,Peehl Donna4,Zhao Hongjuan4,Ning Shoucheng3,Cabrales Pedro5,Summers Thomas A.6,Reid Tony R.7,Fitch William L.8,Kim Michelle M.9,Trepel Jane B.10,Lee Min-Jung10,Kesari Santosh11,Abrouk Nacer D.9,Day Regina M.12,Oronsky Arnold13,Ray Carolyn M.14,Carterg Corey A.6

Affiliation:

1. EpicentRx (no department)

2. Department of Radiology, Stanford University, Palo Alto, CA, USA

3. Department of Radiation Oncology, Stanford University, Palo Alto, CA, USA

4. Department of Urology, Stanford University, Palo Alto, CA, USA

5. Department of Bioengineering, University of California at San Diego (UCSD), La Jolla, CA, USA

6. Murtha Cancer Center, Walter Reed National Military Medical Center; Bethesda, MD, USA

7. Moores Cancer Center, University of California at San Diego (UCSD), CA, USA

8. Department of Anesthesia, Stanford University, Palo Alto, CA, USA

9. Innovexe

10. National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

11. John Wayne Cancer Institute, Providence Saint John’s Health Center, CA, USA

12. Department of pharmacology, Uniformed Services University, Bethesda, MD, USA

13. InterWest Partners

14. Cancer Center, St. Francis Hospital, Hartford, CT, USA

Funder

EpicentRx, Inc

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3